Acetyl-L-Carnitine Hydrochloride in Preventing Peripheral Neuropathy in Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Undergoing Chemotherapy

Clinical trial NCT01492920 · WITHDRAWN

Trial details

NCT number: NCT01492920
Sponsor: Gynecologic Oncology Group
Status: WITHDRAWN
Phase: Phase 3
Study type: INTERVENTIONAL

Fatigue Malignant Ovarian Mixed Epithelial Tumor Neuropathy Neurotoxicity Syndrome Ovarian Brenner Tumor Ovarian Clear Cell Cystadenocarcinoma Ovarian Endometrioid Adenocarcinoma Ovarian Mucinous Cystadenocarcinoma Ovarian Serous Cystadenocarcinoma Pain Recurrent Fallopian Tube Carcinoma Recurrent Ovarian Carcinoma

Start date: 2012-04-01
Primary completion: 2015-05-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.